Press Releases
May 29, 2020
Canopy Growth Reports Full Year and 4th Quarter Fiscal 2020 Financial Results; Provides Strategic Review Update
Generated Net Revenue of $399 million in FY 2020, up 76% over FY 2019 In connection with previously announced organizational and strategic review, recorded impairment and restructuring charges of $743 million; the majority of which are non-cash charges Gross Margin of (85)% in Q4 FY2020; excluding restructuring and other charges, achieved Adjusted Gross Margin of 42% Net Loss of $1.3 billion; Adjusted EBITDA loss of $102 million in Q4 2020 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) today announced its financial results for the fourth quarter and full twelve-month fiscal year ended March…
May 22, 2020
Canopy Growth to Webcast Fourth Quarter and Fiscal Year 2020 Earnings Conference Call on May 29, 2020
Company to host Virtual Investor Meeting on June 22, 2020 MAY 22, 2020 SMITHS FALLS, ON—Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) will release its financial results for the fourth quarter and fiscal year 2020 ended March 31, 2020 before financial markets open on May 29, 2020. Following the release of its fourth quarter and fiscal year 2020 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on May 29, 2020. Webcast Information A live audio webcast will be available at: https://produceredition.webcasts.com/starthere.jsp?ei=1308617&tp_key=850fd370f4…
May 12, 2020
Canopy Growth Continues Its 2.0 Product Innovation Rollout With New Beverage, Chocolate and Vape Products Arriving In Market
SMITH FALLS, ON— Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) officially unveiled its Cannabis 2.0 portfolio in late 2019 and is pleased to provide the following updates on the Company’s 2.0 innovation products that have launched into the Canadian recreational market in early 2020, and additional upcoming product releases. The first wave of the Company’s ready-to-drink cannabis-infused beverages – Tweed Houndstooth & Soda and Tweed Bakerstreet & Ginger — shipped in March 2020 and April 2020, respectively. Houndstooth & Soda — the first THC-infused ready-to-drink beverage to hit the Canadian market — garnered positive early reviews and…
May 1, 2020
Constellation Brands Exercises Warrants to Acquire Shares in Canopy Growth, Reinforcing Confidence in Canopy Growth’s Ability to Win Long-Term in Emerging Cannabis Industry
VICTOR, N.Y. and SMITHS FALLS, Ontario, May 1, 2020 – Constellation Brands, Inc. (“Constellation Brands”) (NYSE: STZ and STZ.B), a leading beverage alcohol company, and Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED, NYSE: CGC), a leading diversified cannabis company, today announced the exercise by Greenstar Canada Investment Limited Partnership, an indirect, wholly-owned subsidiary of Constellation Brands, of an aggregate of 18,876,901 warrants to purchase common shares of Canopy Growth. The warrants, which were originally issued on November 2, 2017, were exercised at an exercise price of C$12.9783 per common share for an aggregate of approximately C$245 million. Upon issuance, the…
April 21, 2020
Clever Leaves and Canopy Growth Announce Regional Supply Agreement
Clever Leaves Colombia to supply extracted products to Canopy LATAM, Canopy Growth’s Latin American Subsidiary BOGOTÁ, Colombia and SMITHS FALLS, ON – April 21, 2020 – Clever Leaves, a leading multinational operator (MNO) and licensed producer of pharmaceutical-grade cannabis and hemp extracts, and Canopy LATAM Corporation (“Canopy LATAM”), a wholly owned and controlled subsidiary of Canopy Growth Corporation (“Canopy Growth”) (TSX:WEED, NYSE:CGC), announce that both parties have entered into a regional supply agreement. Under the terms of the agreement, Clever Leaves will supply Canopy LATAM with extracted products from its GMP-certified, licensed cannabis processing system and cultivation sites in Colombia.…
April 20, 2020
Canopy Growth CBD brand “First & Free” adds topicals to product portfolio
Containing 2500 mg of CBD per tube, creams are the highest strength CBD topical in the US NEW YORK, NY (April 20, 2020) First & Free, an American-made CBD brand from Canopy Growth Corporation (TSX:WEED, NYSE:CGC), today announced a new line of CBD Creams: Everyday, Motion and Revitalize. The creams are the latest addition to First & Free’s portfolio of hemp-derived CBD isolate products including oil drops and softgel capsules, which launched exclusively in the U.S. last December. The new product line includes three distinct topical creams with CBD isolate that has been derived from 100% USA-grown hemp. Each 1.76…
April 16, 2020
Canopy Growth Announces Changes to Global Operations to Drive Strategic Focus
– These actions will further align global supply and demand, streamline operations and improve organizational focus. – Company continues to expect to incur approximately C$700-800MM pre-tax charge in Q4 Fiscal 2020. SMITHS FALLS, ON—Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) today announced a series of global operational changes designed to further optimize production, better align supply and demand, and improve efficiencies in its global operations. As part of its ongoing strategic review of the business, the Company announced today the following changes to its operations: Africa: Canopy Growth plans to exit its operations in South Africa and…
April 9, 2020
This Works Launches 24hr CBD Boosters
Wimbledon, United Kingdom – This Works is pleased to share its first skincare range to feature CBD is now available to purchase exclusively via John Lewis & Partners in the UK and has already been tipped as one of ‘the best new beauty launches this April by Harper’s Bazaar. The range consists of five clinically proven and 98% natural skincare boosters expertly blended with 1% pure hemp-derived CBD isolate and active molecules held in a unique bi-phase serum for powerful results without irritation. Each booster is designed for application alone as an intensive boosting treatment or mixed into a regular…
April 3, 2020
Storz & Bickel’s Volcano Medic 2 Receives Medical Use Approval From Health Canada
SMITHS FALLS, ON & TUTTLINGEN, GERMANY – Storz & Bickel is pleased to announce that Health Canada has issued a Medical Device Licence for the new Volcano Medic 2 (License No.: 103842), an advanced cannabis vapourizer device for medical use. This licence permits distribution to medical institutions, clinics, and patients in Canada – including distribution through Spectrum Therapeutics, the medical cannabis division of Canopy Growth Corporation (TSX:WEED, NYSE:CGC). The device is currently available for purchase on Spectrum Therapeutics, Storz & Bickel’s online shop, and various medical cannabis clinics across Canada. Storz & Bickel is known for their long history of…
April 1, 2020
Canopy Growth Announces Changes to its Board of Directors
Terry Yanofsky and David Lazzarato appointed as John Bell and Peter Stringham retire from the CGC Board. SMITHS FALLS, ON—Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce that Ms. Terry Yanofsky and Mr. David Lazzarato have been appointed to the Company’s Board of Directors, effective immediately. “It is my pleasure to welcome both Terry and David to the board,” said Judy Schmeling, Chair of the Board of Directors, Canopy Growth. “Their leadership and experience in highly competitive industries will be instrumental as we focus the business and evolve into an execution-driven operating company. I…